ERIC 2018 | Genomic discoveries in CLL
Richard Rosenquist
• 25 Oct 2018
The advent of genomics has revealed unexpected mutations in chronic lymphocytic leukemia (CLL), such as those in SF3B1, which is involved in unclear RNA splicing events. Here, Richard Rosenquist, MD, PhD, of the Karolinska University Hospital, Solna, Sweden, compares clinical vs. genetic heterogeneity, and suggests that current challenges lie in sifting through genomic data to understand the effect of low frequency mutations. This video was recorded at the European Research Initiative on CLL (ERIC) International Meeting 2018, held in Barcelona, Spain.
